Insperity, Inc. (NSP) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call revealed disappointing financial results with an EPS miss and lower EBITDA due to high benefits costs. Despite a positive outlook for 2026, the immediate financials are concerning. The Q&A highlighted management's optimism about future recovery and strong sales, but did not address current issues effectively. With a market cap of ~$3.4 billion, the negative financial results and uncertainty in guidance are likely to lead to a negative stock price movement in the short term.
Key Financial Performance
Average number of paid worksite employees Increased by 1.2% year-over-year to 312,842 in Q3 2025. This growth was within the forecasted range, driven by new client sales, although worksite employees paid from new clients slightly decreased compared to Q3 2024.
Client retention Remained strong at 99% per month, consistent with prior year results. Seasonal summer employee departures caused net hiring within the client base to be negative in Q3 2025.
Adjusted EPS Reported as minus $0.20 for Q3 2025, falling below forecasted ranges due to higher-than-expected benefits costs.
Adjusted EBITDA Reported as $10 million for Q3 2025, below forecasted ranges, primarily due to higher-than-expected benefits costs.
Gross profit per worksite employee Decreased to $208 per month in Q3 2025 from $247 in Q3 2024, driven by higher-than-expected benefits costs of $20 million.
Benefits cost trend Increased by 9.1% year-over-year in Q3 2025, driven by higher outpatient and inpatient utilization, pharmacy costs, and a significant increase in large claims frequency.
Operating expenses Decreased by 4% year-over-year in Q3 2025 and declined sequentially by $10 million from Q2 2025. The reduction was primarily in salaries and G&A costs.
Investment in HRScale platform Totaled $17 million in Q3 2025, with $11 million included in operating expenses. This compares to $19 million in Q3 2024, all of which was expensed.
Cash dividends Paid $22 million in Q3 2025, with year-to-date cash dividends totaling $68 million.
Stock repurchase Repurchased 225,000 shares at a cost of $19 million year-to-date in 2025.
Adjusted cash Ended Q3 2025 with $120 million of adjusted cash and $280 million available under the credit facility.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
HRScale Solution Rollout: The HRScale solution, a joint initiative with Workday, is being officially rolled out. It targets mid-market companies with 150 to 5,000 employees. The platform integrates Workday's HR technology with Insperity's HR compliance platform. Beta clients are being onboarded, and the first payroll is expected in April 2026. The solution is expected to be a growth catalyst for Insperity, with significant investment milestones achieved within budget.
Mid-Market and Enterprise Sales Growth: The company reported a 45% increase in booked HR360 sales compared to the same period last year, driven by strong performance in the mid-market and enterprise segments. This includes the largest account sale in the company's history, which will transition to HRScale in the future.
Cost Management and Efficiency: Operating expenses decreased by 4% year-over-year in Q3 2025 and sequentially by $10 million. Investments in the Workday partnership were managed within budget, and a portion of costs was capitalized for the first time.
Health Insurance Cost Management: The company faced a 9.1% increase in benefits costs in Q3 2025 due to higher healthcare claims. Measures include pricing adjustments and a new agreement with UnitedHealthcare to reduce costs and risks starting in 2026.
Strategic Partnership with Workday: The partnership aims to create a unique HR solution for mid-market companies. The HRScale platform is expected to disrupt the market and drive growth.
Three-Year Growth and Profitability Plan: The company is finalizing a plan to return to historical growth and profitability metrics, focusing on double-digit growth, margin improvement, and leveraging AI for operational efficiencies.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Health care claims cost escalation: The company has experienced a significant and unexpected increase in health care claims costs, driven by higher outpatient and inpatient utilization, pharmacy costs, and large claims frequency. This trend has led to a benefits cost trend of 9.1% for Q3 2025 over Q3 2024, and it is expected to persist into 2026. The adoption of AI tools by health care providers has also contributed to higher costs, impacting diagnosis, treatment plans, and insurance billing.
Pricing and profitability challenges: Higher-than-expected benefits costs have outpaced projections, leading to a shortfall in adjusted EPS and adjusted EBITDA for 2025. The company has had to increase pricing targets to address these costs, which could impact client retention and new client acquisition.
Macroeconomic and labor market conditions: The hiring environment remains challenging, with Q3 2025 activity slightly weaker than Q3 2024. This has contributed to restrained growth across the business services sector and impacted the company's ability to achieve higher unit growth.
Strategic execution risks: The rollout of the HRScale solution, while promising, involves significant investment and operational complexity. The success of this initiative is critical to driving future growth and profitability, but it carries risks related to client adoption, implementation, and achieving projected returns on investment.
Dependence on health insurance carriers: The company’s financial performance is heavily influenced by its agreements with health insurance carriers. While a new agreement with UnitedHealthcare is expected to mitigate some risks, any changes in carrier terms or industry trends could adversely impact costs and margins.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Q4 and Full Year 2025 Outlook: Average paid worksite employees expected to range from 313,000 to 315,000 in Q4, representing a 1.3% to 1.9% increase over Q4 2024. Full-year adjusted EPS forecasted between $0.84 and $1.47, and adjusted EBITDA between $119 million and $153 million. Full-year benefits cost trend expected to remain elevated at 9%. Operating expenses for 2025 projected to be 3% below 2024 levels. Q4 adjusted EBITDA forecasted between negative $25 million and $9 million, and adjusted EPS between minus $0.79 and minus $0.16.
2026 Financial Performance Expectations: Elevated benefits cost trend expected to persist. Strategic pricing adjustments and plan cost reductions, including a new contract with UnitedHealthcare, are expected to offset these trends. The contract includes cost savings and a reduction in health care claims risk by lowering the pooling level from $1 million to $500,000. HRScale rollout expected to incrementally impact worksite employee growth and revenue. Operating expenses associated with HRScale in 2026 expected to be about $15 million lower than in 2025. 2026 represents an opportunity to recover a majority of the earnings shortfall experienced in 2025.
HRScale Rollout: HRScale, a joint solution with Workday, is expected to enhance growth in the mid-market segment (150 to 5,000 employees). Active co-marketing and co-selling efforts are underway, with beta clients expected to go live in March 2026. The solution is anticipated to be a significant growth catalyst, with potential to disrupt the market and drive large client sales and retention.
Three-Year Plan: The company aims to return to historical growth and profitability metrics, including double-digit unit revenue and gross profit growth, and adjusted EBITDA annual growth rates above 20%. Initiatives include leveraging HRScale as a growth driver, improving gross profit margins, and achieving operating expense efficiencies through AI initiatives. The plan is designed to generate corresponding shareholder returns.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Regular Dividend Program: During the third quarter, the company paid $22 million in cash dividends. On a year-to-date basis, the company has paid $68 million in cash dividends.
Share Repurchase Program: The company repurchased 225,000 shares of stock at a cost of $19 million year-to-date.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you clarify the opportunity to recover the majority of earnings shortfall?
A:The initial guidance for 2025 and actual results for 2024 were relatively similar. The shortfall this year is primarily due to one issue, and a rebound from three major elements is expected to recover the majority of the shortfall in 2026.
Q:What is the impact of cost trends and repricing on attrition and new sales for 2026?
A:The company has strong sales efforts and does not see pricing changes as misaligned with the market. Sales in Q3 were 45% ahead of last year, and renewal rates were at 99%. While some margin recovery may lead to attrition, it is expected to be offset by new sales.
Q:What are the initial responses from the new pod jointly marketing the joint solution?
A:The responses have been very positive. The pod has developed a comprehensive HRScale solution combining service and technology. They are ahead of schedule, have filled the pipeline, and are receiving great reactions from prospects.
Q:Have there been adjustments to benefits repricing since the first quarter?
A:Yes, pricing adjustments have been made on a rolling monthly basis due to escalating trends. The company has raised price levels throughout the year and expects pricing in 2026 to exceed the current higher rate.
Q:What is the expected benefit cost trend for next year on an apples-to-apples basis?
A:The average increase is expected to be in the low double digits. The company offers tools to help clients mitigate increases, which positions them competitively.
Q:What is the magnitude of managing out lower profitability clients?
A:The company is increasing pricing selectively to retain profitable clients. Terminations are expected to involve lower profitability clients, aligning with the strategy to improve overall profitability.
Q:What are the costs and benefits of lowering the risk mitigation level to $500,000?
A:Lowering the risk mitigation level to $500,000 aligns with a new contract with UHC, providing better alignment and consistency. It reduces immediate costs and addresses elevated claim levels effectively.
Q:Can you provide more detail on HRScale pricing and its impact on offsetting incremental operating and service expenses?
A:HRScale pricing includes a significant uplift in the base price. Discounts are planned for early adopters, but even discounted prices are higher than historical HR360 charges. The two price points for HRScale and HR360 are complementary and support each other.
Q:Can historical double-digit worksite employee growth be achieved despite a sluggish SMB labor market?
A:Yes, the company believes it can achieve double-digit growth due to the new HRScale offering targeting larger clients with 400-700 employees, which is a significant growth catalyst.
Q:Is the $150 million aggregate investment for HRScale still accurate?
A:Yes, the $150 million investment framework remains accurate. Operating expenses include revenue offsets and inefficiencies, but investment levels are expected to decrease significantly after the stabilization period.
Q:How does AI and employment uncertainty impact the midterm framework?
A:AI has not yet caused significant job replacement but may lead to entrepreneurship and new business creation. The company is prepared for potential impacts and sees its new growth engines as well-timed.
Q:Review of Unclear Management Responses
A:Management avoided directly addressing the magnitude of managing out lower profitability clients, providing only general statements about pricing strategies and profitability alignment.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI tool
HRScale catalyst
HRScale solution
PEO
action step
agreement
alignment
care provider
care utilization
claim cost
client receptivity
client tenant
contract
contributor
cost escalation
deployment enablement
development success
effect
enablement client
estimate beginning
health care
health insurance
insurance industry
investment year
issue health
labor market
loss ratio
pillar
rollout HRScale
topic
treatment
NSP Transcript
Insperity, Inc. (NSP) Q1 2026 Earnings Call Transcript
Unknown5-1
The earnings call reflects a mixed sentiment. While the company is optimistic about HRScale's potential and profit recovery, there are challenges like lowered guidance and competitive pricing pressures. The Q&A reveals cautious optimism, with no significant negative surprises but also no strong positive catalysts. The market cap suggests moderate stock volatility. Given the mixed financial performance and guidance, the stock price is expected to remain relatively stable over the next two weeks, resulting in a neutral sentiment rating.
Insperity, Inc. (NSP) Q4 2025 Earnings Call Transcript
Unknown2-10
The earnings call summary presents a mixed outlook. While there are positive elements like the HRScale rollout and strategic partnerships, concerns about elevated benefits costs, uncertain client transitions, and a lack of specific guidance on profitability metrics temper enthusiasm. The Q&A section highlights management's reluctance to provide specific details, adding to uncertainty. Given the company's mid-cap size, these factors suggest a neutral stock price reaction in the short term.
Insperity, Inc. (NSP) Q3 2025 Earnings Call Transcript
Unknown11-4
The earnings call revealed disappointing financial results with an EPS miss and lower EBITDA due to high benefits costs. Despite a positive outlook for 2026, the immediate financials are concerning. The Q&A highlighted management's optimism about future recovery and strong sales, but did not address current issues effectively. With a market cap of ~$3.4 billion, the negative financial results and uncertainty in guidance are likely to lead to a negative stock price movement in the short term.
Insperity, Inc. (NSP) Q2 2025 Earnings Call Transcript
Unknown8-1
The earnings call presents a mixed picture: strong client retention and efficient sales are positive, but reduced growth guidance and declining gross profit per employee are concerns. The Q&A reveals optimism about future growth and strategic initiatives, yet lacks concrete guidance on the Workday partnership's financial impact. The partnership with Workday and share repurchases provide some optimism, but increased healthcare costs and uncertain future projections temper enthusiasm. Given the market cap of $3.44 billion, the stock price is likely to remain stable, resulting in a neutral prediction.
NSP Slides
Insperity Q1 2026 slides: margin recovery gains amid worksite employee decline2026-04-30
Insperity Q4 2025 slides: Profit slump drives recovery focus for 20262026-02-10
Insperity Q3 2025 slides: Benefits costs weigh on earnings despite employee growth2025-11-03
Insperity Q2 2025 slides: Earnings plunge 70% despite worksite employee growth2025-08-01
NSP Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
